Article
Whole‐Genome <scp>mRNA</scp> Expression Profiling Identifies Functional and Prognostic Signatures in Patients with Mesenchymal Glioblastoma Multiforme
11 May 2013
Abstract excerpt
BACKGROUND: The Cancer Genome Atlas (TCGA) has divided patients with glioblastoma multiforme (GBM) into four subtypes based on mRNA expression microarray. The mesenchymal subtype, with a larger proportion, is considered a more lethal one. Clinical outcome prediction is required to better guide more personalized treatment for these patients. AIMS: The objective of this study was to identify a mRNA expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
